Tandem Diabetes Care Inc (NASDAQ: TNDM) stock closed at $21.75 on 2/27/25 after a major decline of -35.2%. Moreover, this decline was accompanied by exceptionally high trading volume at 964% of normal. The stock has been weak relative to the market over the last nine months and has declined -31.4% during the last week.
Current PriceTarget Research Rating
Tandem Diabetes Care has a current Value Trend Rating of F (Lowest Rating). This rating combines consistent signals from two proprietary PTR measures of a stock’s attractiveness. Tandem Diabetes Care has a poor Power Rating of 26 and a very low Appreciation Score of 8, leading to the Lowest Value Trend Rating.
Rating Review
In light of this highly negative price change we are reviewing our current Overall Rating of F. This review will be completed in the next several days.
Be the first to comment